Arcturus Therapeutics (ARCT) Prices 3.26M Share Common Offering at $53/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
After-Hours Movers 07/28: (BGFV) (KODK) (AMD) Higher; (KODK) (RRD) (STX) Lower (more...)
July 28, 2020 6:04 PM EDTToday's After-Hours Movers
Big 5 Sporting Goods (NASDAQ: BGFV) 47% HIGHER; reported Q2 EPS of $0.52, versus $0.00 reported last year. Revenue for the quarter came in at $227.94 million, versus $240.97 million reported last year.
Eastman Kodak Company (NYSE: KODK) 36% HIGHER; adds to 200%+ intra-day gains as Trump mentioned the deal to produce drug ingredients
Community Health Systems (NYSE: CYH) 16.5% HIGHER; reported Q2 EPS of $0.85, $1.47 better than the analyst estimate of ($0.62). Revenue for... More
Arcturus Therapeutics (ARCT) Announces Proposed Public Offering of Common Stock
July 28, 2020 4:15 PM EDTArcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares... More
Arcturus Therapeutics (ARCT) PT Raised to $78 at H.C. Wainwright
July 27, 2020 6:36 AM EDTH.C. Wainwright analyst Ed Arce raised the price target on Arcturus Therapeutics (NASDAQ: ARCT) to $78.00 (from $62.00) while maintaining a Buy rating.... More
